课题基金 / 基金详情

Advancing the clinical development of [18F]AMBF3-TATE, a novel imaging probe for neuroendocrine tumours

Advancing the clinical development of [18F]AMBF3-TATE, a novel imaging probe for neuroendocrine tumours
推进神经内分泌肿瘤新型成像探针[18F]AMBF3-TATE的临床开发
批准号:
325063
负责人:
Benard Francois
金额:
$11.66万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-02-01 至 2016-02-01

项目摘要

项目成果

Benard Francois的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer is the leading cause of death in developed countries including Canada. To reduce the high mortality rate from cancer, new diagnostic tools as well as new treatment options are urgently required. Neuroendocrine tumours (NETs) arise from the neuroend
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of second-generation radiopharmaceuticals targeting the C-X-C chemokine receptor 4 for imaging and therapy of hematological cancers
  • 批准号:
    463499
  • 项目类别:
    Operating Grants
  • 资助金额:
    $62.7万
  • 财政年份:
    2022
  • 负责人:
    Benard Francois
  • 依托单位:
Targeted radiopharmaceuticals to improve cancer diagnosis and treatment
  • 批准号:
    334222
  • 项目类别:
    Operating Grants
  • 资助金额:
    $104.34万
  • 财政年份:
    2015
  • 负责人:
    Benard Francois
  • 依托单位:
Integrating Quantitative Imaging Methods and Genomic Biomarkers to Assess the Therapeutic Response of Cancers
  • 批准号:
    314278
  • 项目类别:
    Operating Grants
  • 资助金额:
    $112.84万
  • 财政年份:
    2014
  • 负责人:
    Benard Francois
  • 依托单位:
Radiometals produced by liquid targets for molecular imaging of cancer
  • 批准号:
    248164
  • 项目类别:
    Operating Grants
  • 资助金额:
    $30.6万
  • 财政年份:
    2011
  • 负责人:
    Benard Francois
  • 依托单位:
海外基金